TREATMENT OF CARDIOVASCULAR RISK IN DIABETIC PATIENTS

TREATMENT OF CARDIOVASCULAR RISK IN DIABETIC PATIENTS

Disclosed herein are methods of treating cardiovascular risk in diabetic patients using a pharmaceutically acceptable form of (Z)-6-((2S,4S,5R)-2-(2-chlorophenyl)-4-(2- hydroxyphenyl)-1,3-dioxan-5-yl)hex-4-enoic acid in combination with a pharmaceutically acceptable form of a P2Y12 inhibitor. La pré...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BENDER, NORBERT, SAKARIASSEN, KJELL, STEINAR, SORENSEN, ALEXANDRA, SANTANA
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed herein are methods of treating cardiovascular risk in diabetic patients using a pharmaceutically acceptable form of (Z)-6-((2S,4S,5R)-2-(2-chlorophenyl)-4-(2- hydroxyphenyl)-1,3-dioxan-5-yl)hex-4-enoic acid in combination with a pharmaceutically acceptable form of a P2Y12 inhibitor. La présente invention concerne des procédés de traitement du risque cardiovasculaire chez les patients diabétiques en utilisant une forme pharmaceutiquement acceptable de l'acide (Z)-6-((2S,4S,5R)-2-(2-chlorophényl)-4-(2- hydroxyphényl)-1,3-dioxan-5-yl)hex-4-enoïque en combinaison avec une forme pharmaceutiquement acceptable d'un inhibiteur de P2Y12.